Richard N. Altice - 14 Oct 2024 Form 4 Insider Report for Danimer Scientific, Inc. (DNMRQ)

Role: Interim CEO, Director
Signature: /s/ Stephen A. Martin, attorney-in-fact
Issuer symbol: DNMRQ
Transactions as of: 14 Oct 2024
Net transactions value: $0
Form type: 4
Filing time: 16 Oct 2024, 16:30:04 UTC
Previous filing: 22 Jul 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DNMR	Stock Appreciation Rights	Award	$0	+300,000		$0.000000	300,000	14 Oct 2024	Common Stock	300,000	$0.5500	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These stock appreciation rights (SARs) to purchase shares of the Issuer's Class A common stock ("Common Stock") were granted to Reporting Person on October 14, 2024 under the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan (the "Plan"). SARs to purchase 300,000 shares of the Issuer's Common Stock will vest and become exercisable on October 14, 2025 subject to recipient's continued service as a director of the Company.

Content

These stock appreciation rights (SARs) to purchase shares of the Issuer's Class A common stock ("Common Stock") were granted to Reporting Person on October 14, 2024 under the Danimer Scientific, Inc. 2020 Long-Term Incentive Plan (the "Plan"). SARs to purchase 300,000 shares of the Issuer's Common Stock will vest and become exercisable on October 14, 2025 subject to recipient's continued service as a director of the Company.